News

By combining data from sources that at first seemed to be incompatible, UC San Francisco researchers have identified a molecular signature in tissue adjacent to tumors in eight of the most common cancers that suggests they are all using the same mechanism to remodel normal tissue and spread. The new

The National Cancer Institute (NCI) has announced that UC San Francisco will host one of five new Cancer Drug Resistance and Sensitivity Centers being set up around the U.S. through funding from the 21st Century Cures Act of 2016. The center, a collaboration with researchers at Stanford University

Two of the sharpest minds in the field of cancer virology are scheduled to present the Maurice, Ethel, and Jane Sokolow Memorial Cancer Endowment Lectureship at the HDFCCC on October 25th and 26th. Yuan Chang, MD, and Patrick S. Moore, MD, MPH, from the University of Pittsburgh Cancer Institute

Cigarette smokers with high levels of psychological distress are often heavy smokers, and thus identified as a “hard core” group who are less willing or able to quit than other smokers. However, a study by UC San Francisco researchers shows that over the course of 19 years, from 1997 to 2015, this

​ The National Institutes of Health (NIH) has awarded grants to two UC San Francisco researchers to pursue innovative approaches to major contemporary challenges in biomedical research. The highly competitive grants, which were announced Oct. 5 among 86 such awards nationwide, were made under the

Today two widely respected and accomplished breast cancer investigators join the ranks of an esteemed group of scientists as recipients of this year’s Brinker Awards – the highest scientific honor awarded by Susan G. Komen, the world’s leading breast cancer organization. Established by Komen in 1992

Strata Oncology, Inc. (Strata), a precision oncology company, announced a collaboration with the University of California San Francisco (UCSF) to launch StratifyProstateTM a unique initiative focused on expanding access to tumor sequencing nationwide for men with advanced prostate cancer and to